Why some people got blood clots after the AstraZeneca vaccine – new clues
@rt.com4 years ago
Argentina 2nd to approve Oxford-AstraZeneca Covid-19 jab, as EU expected to soon follow suit
@rt.com4 years ago
AstraZeneca’s Covid-19 vaccine shows average efficiency of 70%
@forbes.com5 years ago
AstraZeneca Covid-19 Coronavirus Vaccine Begins Phase 3 Trial In U.S.
@WSJ5 years ago
AstraZeneca has signed new agreements aimed at broadening global distribution of a coronavirus vaccine being developed by researchers on.wsj.com
@cjr.org4 years ago
The AstraZeneca vaccine and our ongoing uncertainty problem
@dailywire.com4 years ago
U.K. Becomes First Nation To Approve AstraZeneca Coronavirus Vaccine
@abc.net.au4 years ago
AstraZeneca says COVID-19 vaccine developed with Oxford can be up to 90 per cent effective
@dailywire.com5 years ago
AstraZeneca Might Receive Emergency Use Authorization For Its Coronavirus Vaccine — In October: Report
@dailywire.com5 years ago
U.S. Gives $1.2 Billion To UK Attempt At Vaccine, 300 Million Doses Could Be Ready By October
@cjr.org4 years ago
Political warfare, inequity, and insufficient data in coverage of the vaccine rollout
@nytimesworld4 years ago
Britain became the first country to give emergency authorization to the coronavirus vaccine developed by AstraZeneca and the University of Oxford. Follow our updates on the pandemic: nyti.ms
@rt.com4 years ago
AstraZeneca vaccine volunteer developed spinal inflammation & ‘rare neurological condition’ after two doses – report
@forbes.com5 years ago
Promising Sign As Coronavirus Vaccine Developed By AstraZeneca And Oxford University Appears Safe, Early Trials Show
@nytimesworld4 years ago
An 82-year-old in Britain became the first person in the world to receive the clinically authorized, fully tested coronavirus vaccine developed by the University of Oxford and AstraZeneca. Follow our updates on the pandemic. nyti.ms
@abc.net.au4 years ago
UK approves Oxford-AstraZeneca COVID-19 vaccine
@nytimesworld5 years ago
The drug company AstraZeneca has paused its coronavirus vaccine trials after a participant developed a serious illness. The company is investigating whether it was tied to the vaccine. nyti.ms
@WSJ5 years ago
A leading coronavirus-vaccine candidate being developed by University of Oxford researchers and pharmaceutical company AstraZeneca showed positive results in early trials, raising the prospect that a shot could be available by the end of this year on.wsj.com